Orthocell (ASX:OCC) announced the start of Phase 2 trials in 2011... but this was never verified (http://ausbiotech2011.com.au/uploads/Orthocell.pdf)
At this stage, the use of MSCs in Phase 2 trials seems to be only happening with RGS and MSB, indeed.
Ann: Positive clinical trial results for Progenza, page-12
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
